Home | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer.

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. has 5 revisions.
RevisionStatus
Saved 31/07/2023 - 12:34pm by ROCHE
in draft/pending publication
Saved 19/07/2023 - 4:03pm by Gladys
current revision (published)
Saved 18/08/2021 - 12:07pm by ROCHE

Buen día estimados, A continuación la más reciente actualización del estudio. Saludos,

archived
Saved 17/08/2021 - 1:43pm by ROCHE
archived
Saved 10/07/2018 - 9:48am by Gladys
archived